Skip to main content

Table 2 Multivariate analysis for SMI and SMD with Cox regression for overall survival

From: Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study

  

HR

95% CI

P

SMI

High

1

   

Low

1.352

1.03

1.78

0.032

SMD

High

1

   

Low

1.451

1.09

1.93

0.011

Low SMI and low SMD

No

1

   

Yes

1.579

1.12

2.23

0.010

  1. CI confidence interval, HR hazard ratio, OS overall survival, SMD skeletal muscle density
  2. SMI, SMD, and co-presence of low SMI and low SMD were individually adjusted for age, sex, ECOG, location, histological type, number of metastatic organs, CA19–9, first line chemotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us